Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Blood Test Could Detect Infection Exposure History

By LabMedica International staff writers
Posted on 02 Feb 2026

Every infection leaves a lasting imprint on the immune system, but current diagnostic tools can usually detect exposure to only one pathogen at a time. More...

This makes it difficult to understand a person’s full infection history or immune protection using a simple test. Because immune responses vary widely between individuals, this diagnostic potential remains largely untapped. Researchers are now working toward a blood-based approach that could reconstruct lifelong exposure to infections by reading immune cell signatures.

T-cells detect infections through highly specific surface sensors known as T-cell receptors, each designed to bind a particular antigen. When a matching antigen is encountered, the corresponding T-cells multiply rapidly. While most die after clearing the infection, a subset remains as memory T-cells, preserving a record of that encounter. Researchers at the University of Erlangen-Nuremberg (FAU, Erlangen, Germany), in collaboration with the University Hospital Erlangen (Erlangen, Germany), have shown that exposure to a pathogen leads to the expansion of many T-cell clones, creating detectable patterns in the blood.

Although individual T-cell receptors differ greatly between people, infections often generate shared or even identical receptor sequences across multiple individuals. These recurring patterns form what researchers describe as an immunological fingerprint. By comparing T-cell receptor sequences from individuals with confirmed past infections, the team aims to identify receptor features specific to particular pathogens. Machine learning algorithms will be used to analyze these large datasets and link receptor patterns to known infectious diseases.

The researchers are initially focusing on viruses that can cause complications during pregnancy, such as rubella. One goal is to assess whether vaccinated or previously infected individuals, including pregnant women, still retain protective immunity by analyzing their T-cell profiles. This approach could complement or even extend beyond traditional antibody-based serological tests. In the long term, the team plans to build libraries of pathogen-specific T-cell receptors and contribute to a global database. This could allow a single blood test to provide a comprehensive overview of an individual’s infection history and immune status across their lifetime.

“Each infection leaves a trace in the immune system. For example, if you have ever had the flu, you will have more T-cells whose receptors match the flu virus antigens than someone who has not.” said Professor Kilian Schober, PhD, lead investigator. “In future, a single test may be sufficient to illustrate an individual’s infection history over their entire lifetime.”

Related Links:
FAU
University Hospital Erlangen


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The addition of Biocare’s complementary IHC antibody, reagent and instrument portfolio enhances Agilent’s immunohistochemistry offering (Photo courtesy of Biocare Medical)

Agilent Technologies Acquires Pathology Diagnostics Company Biocare Medical

Agilent Technologies (Santa Clara, CA, USA) has entered into a definitive agreement to acquire Biocare Medical (Pacheco, CA, USA), expanding its pathology portfolio through the addition of highly complementary... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.